Could Tissue Engineering Mean Personalized Medicine?

[Spaghetti]

"Personalized medicine is the art and science of “coupling established clinical–pathological indexes with state-of-the-art molecular profiling to create diagnostic, prognostic and therapeutic strategies precisely tailored to each patient’s requirements.” The clinical development and regulatory approval of targeted agents that have therapeutic benefit in molecularly defined patient subsets has highlighted the value of personalized medicine, which can be leveraged in clinical trials so that the identification of eligible patients for certain trials is optimized based on the patient’s molecular testing. These targeted patient groups are often rare and expensive to identify, particularly in the field of oncology, making clinical trials targeting these populations difficult to enroll."

Optimizing Oncology Clinical Trials with Personalized Medicine

Biomimetic Microsystems : Wyss Institute at Harvard

FDA Releases Report on Personalized Medicine - Pharmaceutical Technology